Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes.
Coomans de Brachène A, Castela A, Op de Beeck A, Mirmira RG, Marselli L, Marchetti P, Masse C, Miao W, Leit S, Evans-Molina C, Eizirik DL.
Coomans de Brachène A, et al. Among authors: eizirik dl.
Diabetes Obes Metab. 2020 Oct;22(10):1827-1836. doi: 10.1111/dom.14104. Epub 2020 Jul 5.
Diabetes Obes Metab. 2020.
PMID: 32476252
Free PMC article.